Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > WHEN NEWS IS INTRICATE OR COMPLEX

<< Previous

Bullboard Posts

Next >>

Comment by bligickaon Feb 16, 2021 5:02pm

96 Views

Post# 32579805

RE:RE:WHEN NEWS IS INTRICATE OR COMPLEX

Is it ok to release your financials late ???

Do the regulators care if your late, does the market care ???

bligicka wrote: No I don't think delays are acceptable ....Doesn't Goren want to show us he's reliable ???

Charleyfarley wrote:
Delays are inevitable